文献速递炎症性肠病

母亲肥胖与炎症性肠病不良妊娠结局相关:匹配电子健康记录队列研究

Maternal Obesity Is Associated With Adverse Pregnancy Outcomes in Inflammatory Bowel Disease: A Matched Electronic Health Record Cohort Study.
PubMed 文献 · Aliment Pharmacol Ther · 2026-10-28

该研究评估炎症性肠病(IBD)女性妊娠早期肥胖患病率及其与不良妊娠结局的关联。22.6%的IBD妊娠符合肥胖标准,肥胖独立关联复合不良妊娠结局(OR 1.63),而IBD诊断本身无显著额外关联。阿司匹林和低分子肝素预防性处方有待改善。

要点

  • IBD女性妊娠早期肥胖患病率为22.6%(64/283)。
  • 肥胖独立增加复合不良妊娠结局风险(OR 1.63,95%CI 1.15-2.33)。
  • IBD诊断本身未显示显著额外妊娠风险(OR 0.74,P=0.073)。

核心结论

  • IBD女性中超过五分之一妊娠合并肥胖,肥胖与不良妊娠结局强相关。
  • 本研究未发现IBD诊断本身带来显著额外妊娠风险。

研究设计与样本

  • 匹配电子健康记录队列研究,评估妊娠早期BMI。
  • 达到24周的妊娠按母亲年龄、BMI、吸烟状态和孕次进行1:6倾向评分匹配。

主要发现

  • IBD妊娠中22.6%(64/283;95%CI 17.7%-27.5%)符合种族校正肥胖标准。
  • 肥胖等级增加与妊娠期糖尿病、子痫前期、静脉血栓栓塞、急诊剖宫产和高出生体重逐步增加相关。
  • 匹配后177例IBD妊娠和1062例对照,肥胖独立关联复合不良妊娠结局(OR 1.63;95%CI 1.15-2.33;p=0.007)。
  • IBD诊断单独无统计学显著额外关联(OR 0.74;95%CI 0.53-1.03;p=0.073)。
  • IBD妊娠中39.3%(86/219)推荐阿司匹林,21.6%(19/88)事后归类为中高VTE风险者处方低分子肝素。

临床怎么用

  • 对IBD妊娠女性应关注孕前和妊娠早期肥胖管理。
  • 按风险推荐阿司匹林和低分子肝素预防,以改善产前保健。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We sought to define the prevalence of obesity in the first trimester of pregnancy among women with inflammatory bowel disease (IBD) and evaluate its association with adverse pregnancy outcomes. METHODS: First-trimester body mass index (BMI) was assessed in pregnancies with and without IBD. Pregnancies reaching 24 weeks were propensity-score matched 1:6 by maternal age, BMI, smoking status and gravidity to assess whether IBD conferred additional pregnancy risk. RESULTS: Overall, 22.6% (64/283; 95% CI 17.7%-27.5%) of pregnancies in women with IBD met ethnicity-adjusted criteria for obesity. Increasing obesity class was associated with stepwise increases in gestational diabetes, pre-eclampsia, venous thromboembolism (VTE), emergency caesarean section and high birthweight. Matching yielded 177 IBD pregnancies and 1062 controls. Obesity was independently associated with the composite adverse pregnancy outcome (OR 1.63; 95% CI 1.15-2.33; p = 0.007), whereas no statistically significant additional association was identified for IBD diagnosis alone (OR 0.74; 95% CI 0.53-1.03; p = 0.073). Among IBD pregnancies, aspirin was recommended in 39.3% (86/219). Low-molecular-weight heparin (LMWH) was prescribed in 21.6% (19/88) of pregnancies classified post hoc as intermediate or high VTE risk. CONCLUSION: More than one in five pregnancies in women with IBD were complicated by obesity. Obesity was strongly associated with adverse pregnancy outcomes, whereas this study did not identify a significant additional effect attributable to IBD diagnosis alone. Preventive prescribing with aspirin and LMWH represents an opportunity for improved antenatal care.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Roberts C, Smith R, Odeh S, et al. Maternal Obesity Is Associated With Adverse Pregnancy Outcomes in Inflammatory Bowel Disease: A Matched Electronic Health Record Cohort Study. Aliment Pharmacol Ther. 2026. PMID: 42951864. doi:10.1111/apt.71073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。